CD4 and glioblastoma: In GBM-implanted mouse models, the decrease of Tregs led to the proliferation of CD4+ T cells and decreased the levels of secreted immunosuppressive cytokines, resulting in tumor rejection and significantly prolonged mouse survival (27).